600196 (600196) News
Follow 600196 (600196) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Shanghai Fosun Pharmaceutical Group's Unit Signs Licensing Deal With Amberstone
Shanghai Fosun Pharmaceutical Group Co Ltd SSE:600196
NEWS | Sep 23, 2026, 08:49 AM UTC
L
Fosun Pharma plans up to HK$1 billion H-share buyback
Fosun Pharmaceutical Group plans an H-share buyback of up to HK$1 billion.
EQUITY | Sep 06, 2026, 10:43 AM UTC
L
Fosun Pharma unit sells Gland Pharma shares for $294 million
Shanghai Fosun Pharmaceutical Group Co Ltd’s unit sold Gland Pharma shares for $294 million, according to TradingView News.
EQUITY | Sep 06, 2026, 08:57 AM UTC
L
Fosun Pharma sells 4.5% stake in Gland Pharma via block deal
Promoter Fosun Pharma sold equity shares worth more than Rs 2,121 crore in Hyderabad-based Gland Pharma on September 4 through open-market transactions, with the sale representing a 4.5% stake, per NSE block-deal data.
EQUITY | Sep 04, 2026, 05:26 PM UTC
M
Shanghai Fosun Pharma gets conditional NMPA approval for GR1803
Shanghai Fosun Pharma received marketing registration approval with conditions for GR1803 from the NMPA.
EQUITY | Aug 27, 2026, 05:58 PM UTC